Walvax Biotechnology develops, makes, and sells vaccines and biopharmaceutical products. Its products include pediatric and adult vaccines, and it serves hospitals, clinics, public health agencies, and other healthcare providers.
Walvax Biotechnology products and services overview:
Revenue: ~$600 million
Employees: 7,000
Headquarters: Kunming, China
Walvax Biotechnology is one of the...
Walvax Biotechnology is a company listed under the stock ticker 300142 (CN).
View the org chart displaying its 6 main executives
Create your alert
to follow the executive moves at Walvax Biotechnology.
Walvax Biotechnology has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.